These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 32785853

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
    Managuli RS, Raut SY, Reddy MS, Mutalik S.
    Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor.
    Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, Keirns JJ.
    J Pharm Sci; 1998 Feb; 87(2):164-9. PubMed ID: 9519148
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.
    Cho HJ, Kim JE, Kim DD, Yoon IS.
    Drug Dev Ind Pharm; 2014 Aug; 40(8):989-98. PubMed ID: 23981203
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol.
    Itin C, Barasch D, Domb AJ, Hoffman A.
    Int J Pharm; 2020 May 15; 581():119276. PubMed ID: 32243971
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Presystemic extraction: mechanisms and consequences.
    Greenblatt DJ.
    J Clin Pharmacol; 1993 Jul 15; 33(7):650-6. PubMed ID: 8366190
    [Abstract] [Full Text] [Related]

  • 35. Using the Absorption Cocktail Approach to Assess Differential Absorption Kinetics of Cannabidiol Administered in Lipid-Based Vehicles in Rats.
    Izgelov D, Regev A, Domb AJ, Hoffman A.
    Mol Pharm; 2020 Jun 01; 17(6):1979-1986. PubMed ID: 32352800
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Application of Oil-in-Water Cannabidiol Emulsion for the Treatment of Rheumatoid Arthritis.
    Jelínek P, Roušarová J, Ryšánek P, Ježková M, Havlůjová T, Pozniak J, Kozlík P, Křížek T, Kučera T, Šíma M, Slanař O, Šoóš M.
    Cannabis Cannabinoid Res; 2024 Feb 01; 9(1):147-159. PubMed ID: 36342775
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The effect of piperine on oral absorption of cannabidiol following acute vs. chronic administration.
    Izgelov D, Domb AJ, Hoffman A.
    Eur J Pharm Sci; 2020 May 30; 148():105313. PubMed ID: 32198013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.